Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-11-17

FDA Approved: LEVETIRACETAM — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approves a supplemental application for levetiracetam by Actavis Pharma, Inc., approving an updated generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)